A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Advance Solid Tumors

Interventions

DRUG: KIVU-107

Sponsor

Kivu Bioscience Inc.